199 related articles for article (PubMed ID: 15076241)
1. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.
Peyrière H; Reynes J; Rouanet I; Daniel N; de Boever CM; Mauboussin JM; Leray H; Moachon L; Vincent D; Salmon-Céron D
J Acquir Immune Defic Syndr; 2004 Mar; 35(3):269-73. PubMed ID: 15076241
[TBL] [Abstract][Full Text] [Related]
2. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Karras A; Lafaurie M; Furco A; Bourgarit A; Droz D; Sereni D; Legendre C; Martinez F; Molina JM
Clin Infect Dis; 2003 Apr; 36(8):1070-3. PubMed ID: 12684922
[TBL] [Abstract][Full Text] [Related]
5. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-associated renal and bone toxicity.
Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.
Kapadia J; Shah S; Desai C; Desai M; Patel S; Shah AN; Dikshit RK
Indian J Pharmacol; 2013; 45(2):191-2. PubMed ID: 23716900
[TBL] [Abstract][Full Text] [Related]
8. Renal safety of tenofovir in HIV treatment-experienced patients.
Izzedine H; Isnard-Bagnis C; Hulot JS; Vittecoq D; Cheng A; Jais CK; Launay-Vacher V; Deray G
AIDS; 2004 Apr; 18(7):1074-6. PubMed ID: 15096814
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
10. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
11. Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
Heron JE; Bloch M; Vanguru V; Saunders J; Gracey DM
BMC Nephrol; 2020 Aug; 21(1):339. PubMed ID: 32787843
[TBL] [Abstract][Full Text] [Related]
12. Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
Calza L; Trapani F; Salvadori C; Magistrelli E; Manfredi R; Colangeli V; Di Bari MA; Borderi M; Viale P
Scand J Infect Dis; 2013 Feb; 45(2):147-54. PubMed ID: 22991923
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
[TBL] [Abstract][Full Text] [Related]
14. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
[No Abstract] [Full Text] [Related]
15. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction.
Mauss S; Berger F; Schmutz G
AIDS; 2005 Jan; 19(1):93-5. PubMed ID: 15627039
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
18. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
[TBL] [Abstract][Full Text] [Related]
19. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
Badiou S; De Boever CM; Terrier N; Baillat V; Cristol JP; Reynes J
J Infect; 2006 May; 52(5):335-8. PubMed ID: 16176835
[TBL] [Abstract][Full Text] [Related]
20. The clinical and pathological features of adefovir dipivoxil-related renal impairment
.
Lv Y; Li X; Liang S; Liang D; Xu F; Zhu X; Zeng C
Clin Nephrol; 2019 Mar; 91(3):180-186. PubMed ID: 30614440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
